Cormorant Asset Management key facts
- Cormorant Asset Management is a venture capital firm based in Boston, MA with 39 tracked portfolio companies.
- Notable positions include Freenome, Neurona Therapeutics, Parabilis Medicines.
- Cormorant Asset Management reports $773.0M in regulatory assets under management across 7 private funds, per its SEC Form ADV (2026-03).
Investment focus
Its SEC Form ADV lists $773 million in regulatory assets under management across 7 private funds (Mar 2026).
Cormorant Asset Management portfolio at a glance
39 portfolio companies are on record for Cormorant Asset Management, including Freenome, Neurona Therapeutics and Parabilis Medicines.
33 of the 39 carry a recorded valuation.
Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.
Cormorant Asset Management at the SEC
Form ADV · 2026-03 · CRD 167820- Regulatory AUM
- $773.0M
- Private fund assets
- $3.8B
- Private funds
- 7 · 6 private equity, 1 hedge
- Staff
- 12
- Registered office
- BOSTON, MA
- SEC status
- Approved
Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as CORMORANT ASSET MANAGEMENT, LP).
Free account
See more of the book
- ·The top 10 names in the book — of 39 recorded positions
- ·Watchlist + alerts for Cormorant Asset Management's activity
Portfolio
39 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Freenome | Decision/Risk Analysis | ▮ | ▮ | ▮ |
| Neurona Therapeutics | Drug Discovery | ▮ | ▮ | ▮ |
| Parabilis Medicines | Drug Discovery | ▮ | ▮ | ▮ |
+ 36 more companies · all 39, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | ||||
Frequently asked about Cormorant Asset Management
- What companies does Cormorant Asset Management invest in?
- Cormorant Asset Management has 39 recorded portfolio companies, including Freenome, Neurona Therapeutics, Parabilis Medicines.